Protein Design Labs Names Jon Saxe President; Laurence Korn Will Remain CEO and Chairperson CDC Daily UpdateImportant note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow



Protein Design Labs Names Jon Saxe President; Laurence Korn Will Remain CEO and Chairperson

PR Newswire (12/28/94)


Jon S. Saxe has been named President of Protein Design Labs, Inc. (PDL), whose Human Anti-CMV Antibody has completed Phase I or Phase I/II trials for CMV retinitis in AIDS patients and for other CMV infections. Saxe will report to Dr. Laurence Jay Korn, who is currently President, CEO, and Chairperson of the Board of Directors. Korn will remain CEO and Chairperson. "Jon has made numerous contributions to PDL as a director and consultant to the Company, particularly in developing productive relationships with our Japanese and European pharmaceutical partners," said Korn. While directing licensing and corporate development at Hoffmann-La Roche, Saxe helped create relationships between Roche and many other pharmaceutical and biotechnology companies, including Glaxo Inc.


941229
AD942332


Copyright © 1994 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.